Reducing the O-GlcNAcylation in prostate cancer leads to a decrease in the level of c-Myc protein O-GlcNAcylation and decreased c-Myc stability, which researchers have associated with decreased cancer cell growth [77]. This evidence concerns the gene MYC and prostate carcinoma.